Search
Descriptor English: Nateglinide
Descriptor Spanish: Nateglinida
Descriptor nateglinida
Entry term(s) A 4166
A-4166
A4166
AY 4166
AY-4166
AY4166
DJN 608
N-((4-isopropilciclohexil)carbonil)fenilalanina
Starlix
fastic
isómero (D-Phe) de la nateglinida
isómero (cis,D-Phe) de la nateglinida
nate-Glinida
senaglinida
starsis
Scope note: Derivado de fenilalanina y ciclohexano que actúa como hipoglucemiante al estimular la liberación de insulina por el páncreas. Se usa en el tratamiento de la DIABETES MELLITUS DE TIPO 2.
Descriptor Portuguese: Nateglinida
Descriptor French: Natéglinide
Entry term(s): A 4166
A-4166
A4166
AY 4166
AY-4166
AY4166
DJN 608
Fastic
N-((4-Isopropylcyclohexyl)carbonyl)phenylalanine
Nate-Glinide
Nateglinide, (D-Phe)-isomer
Nateglinide, (cis,D-Phe)-isomer
Senaglinide
Starlix
Starsis
Tree number(s): D02.455.426.392.368.367.745
D12.125.072.050.685.448
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000077715
Scope note: A phenylalanine and cyclohexane derivative that acts as a hypoglycemic agent by stimulating the release of insulin from the pancreas. It is used in the treatment of TYPE 2 DIABETES.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Hypoglycemic Agents
Registry Number: 41X3PWK4O2
CAS Type 1 Name: D-phenylalanine, N-((trans-4-(1-methylethyl)cyclohexyl)carbonyl)-
Public MeSH Note: 2019; NATEGLINIDE was indexed under PHENYLALANINE/analogs & derivatives and CYCLOHEXANES 1989-2018
History Note: 2019 (1989)
DeCS ID: 57728
Unique ID: D000077715
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2018/04/09
Nateglinide - Preferred
Concept UI M0353981
Scope note A phenylalanine and cyclohexane derivative that acts as a hypoglycemic agent by stimulating the release of insulin from the pancreas. It is used in the treatment of TYPE 2 DIABETES.
Preferred term Nateglinide
Entry term(s) Nate-Glinide
Senaglinide
Fastic - Narrower
Concept UI M0462936
Preferred term Fastic
Starsis - Narrower
Concept UI M0462935
Preferred term Starsis
DJN 608 - Narrower
Concept UI M0448757
Preferred term DJN 608
AY 4166 - Narrower
Concept UI M0167165
Preferred term AY 4166
Entry term(s) AY-4166
AY4166
A 4166 - Narrower
Concept UI M0167169
Preferred term A 4166
Entry term(s) A-4166
A4166
Nateglinide, (D-Phe)-isomer - Narrower
Concept UI M0324244
Preferred term Nateglinide, (D-Phe)-isomer
Starlix - Narrower
Concept UI M0402899
Preferred term Starlix
N-((4-Isopropylcyclohexyl)carbonyl)phenylalanine - Related but not broader or narrower
Concept UI M000641343
Preferred term N-((4-Isopropylcyclohexyl)carbonyl)phenylalanine
Nateglinide, (cis,D-Phe)-isomer - Narrower
Concept UI M0324245
Preferred term Nateglinide, (cis,D-Phe)-isomer



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey